• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT LABORATORIES ARCHITECT INSULIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT LABORATORIES ARCHITECT INSULIN Back to Search Results
Catalog Number 08K41-26
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/21/2014
Event Type  malfunction  
Event Description
The customer stated that the architect analyzer generated falsely elevated insulin results on one patient sample.Sid (b)(6) initial insulin on (b)(6) 2014 = >300uu/ml / 1:2 dilution result = >600uu/ml.The patient sample was sent out and the lumipulse result = 2.0uu/ml.There was no additional patient information provided.There was no reported impact to patient management.
 
Manufacturer Narrative
(b)(4).An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Manufacturer Narrative
Further evaluation of the customer issue included a review of the complaint text, a review for similar complaints, accuracy testing, and a review of labeling.The customer reported falsely elevated insulin results.A review of complaints did not identify any issues for falsely elevated insulin results for lot 33020lp52.Accuracy testing was completed using retained kits of reagent lot 33020lp52.A deficiency was not identified as the testing showed that lot 33020lp52 performed per specification.The testing showed that acceptance criteria were met, which indicates the product is performing acceptably.No malfunction was identified.A review of labeling determined that the assay values were obtained with different methods, which cannot be used interchangeably, due to differences in assay methods and reagent specificity.No additional issues were identified; no further action is required at this time.Based on the investigation results there is no indication of a product deficiency and the architect insulin reagent is performing as intended.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT INSULIN
Type of Device
INSULIN
Manufacturer (Section D)
ABBOTT LABORATORIES
100 abbott park road
abbott park IL 60064 350
Manufacturer (Section G)
ABBOTT LABORATORIES
100 abbott park road
abbott park IL 60064 350
Manufacturer Contact
noemi romero-kondos, rn bsn
100 abbott park road
dept. 09b9, lccp1-3
abbott park, IL 60064-3537
847937-512
MDR Report Key3708272
MDR Text Key4245117
Report Number1415939-2014-00077
Device Sequence Number1
Product Code CFP
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 03/06/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/28/2014
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date07/16/2014
Device Catalogue Number08K41-26
Device Lot Number33020LP52
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/28/2014
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/01/2013
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
SERIAL # (B)(4); SERIAL # (B)(4); ARCHITECT I2000 ANALYZER, LIST # 08C889-01,; ARCHITECT I2000 ANALYZER, LIST # 08C889-01,
-
-